Lipoproteins and Cardiovascular Health

76 та иш

1. ASSOTIATION OF THE GENETIC POLYMORPHISM E670G OF THE PCSK-9 AND THE SEVERITY OF THE CAROTID ATHEROSCLEROSIS IN PATIENTS WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA IN UZBEK POPULATION

   Rano B. Alieva, Shavkat U. Hoshimov, Sh. S. Ahmedova +3

   МақолаLipoproteins and Cardiovascular HealthEurasian heart journal20190 иқтибос

   ABIABI:AkademIndex/openalex/2019.article.001033

2. STATINS IN ACUTE CORONARY SYNDROMES

   A. L. Alyavi, S. R. Kenjaev, D. A. Alimov +4

   МақолаLipoproteins and Cardiovascular HealthEurasian heart journal20190 иқтибос

   ABIABI:AkademIndex/openalex/2019.article.002150

3. EFFECT OF ATORVASTATIN ON THE FUNCTIONAL STATE OF THE KIDNEYS IN PATIENTS WITH ACUTE CORONARY SYNDROME WHO UNDERWENT PERCUTANEOUS CORONARY ANGIOPLASTY

   S. K. Abdusattarova, Ali Alavy, S. R. Kenjaev

   МақолаLipoproteins and Cardiovascular HealthDOAJ (DOAJ: Directory of Open Access Journals)20190 иқтибос

   ABIABI:AkademIndex/openalex/2019.article.002250

4. Calibration and discrimination of the Framingham Risk Score and the Pooled Cohort Equations

   Dennis T. Ko, Atul Sivaswamy, Maneesh Sud +11

   МақолаLipoproteins and Cardiovascular HealthCanadian Medical Association Journal20200 иқтибос

   ABIABI:AkademIndex/openalex/2020.article.000046

5. Influence of combined lipid lowering therapy on lipid components and interleukins in dyslipidemic patients with coronary artery disease after PCI

   Jamol Uzokov, Bakhromkhon Alyavi, A. Abdullaev

   МақолаLipoproteins and Cardiovascular HealthAtherosclerosis20200 иқтибос

   ABIABI:AkademIndex/openalex/2020.article.000604

6. Modern Hypolipidemic Therapy in Patients with Arterial Hypertension with High Cardiovascular Risk Under Conditions of Long-Term Ambulatory Observation

   Ruziyeva Amira Asrorovna, Muradova Railya Rustamovna, Turaev Khikmatulla Negmatovich +1

   МақолаLipoproteins and Cardiovascular HealthInternational Journal of Current Research and Review20200 иқтибос

   ABIABI:AkademIndex/openalex/2020.article.000785

7. Evaluation of the comparative effectiveness of rosuvastatin and atorvastatin in patients with heart failure

   U. K. Kamilova, Nuriddin Nuritdinov

   МақолаLipoproteins and Cardiovascular HealthAtherosclerosis20200 иқтибос

   ABIABI:AkademIndex/openalex/2020.article.000823

8. Prognostic signs of an unfavorable course of coronary heart disease in patients with type 2 diabetes mellitus

   Yu.М. Urmanova, Sh.Sh. Mukhtarova, Ashley Grossman +2

   МақолаLipoproteins and Cardiovascular HealthINTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine)20200 иқтибос

   ABIABI:AkademIndex/openalex/2020.article.003093

9. Prevalence and Features of Aspirin Resistance in Patients with Coronary Artery Disease

   Khodjanova SH

   МақолаAntiplatelet Therapy and Cardiovascular DiseasesCross Current International Journal of Medical and Biosciences20200 иқтибос

   ABIABI:AkademIndex/openalex/2020.article.005217

10. Reinforcing Adherence to Lipid-lowering Therapy after an Acute Coronary Syndrome: A Pragmatic Randomized Controlled Trial

    Stefanos Zafeiropoulos, Ioannis T. Farmakis, Αναστάσιος Κάρτας +6

    ПрепринтLipoproteins and Cardiovascular HealthResearch Square20200 иқтибос

    ABIABI:AkademIndex/openalex/2020.preprint.000048

11. Reinforcing Adherence to Lipid-lowering Therapy after an Acute Coronary Syndrome: A Pragmatic Randomized Controlled Trial

    Stefanos Zafeiropoulos, Ioannis T. Farmakis, George Giannakoulas +1

    ПрепринтLipoproteins and Cardiovascular HealthResearch Square20200 иқтибос

    ABIABI:AkademIndex/openalex/2020.preprint.000099

12. Aspirin Resistance in Patients with Chronic Coronary Syndrome

    A. L. Alyavi, Sh.I.Khodjanova, Jamol Uzokov +1

    МақолаAntiplatelet Therapy and Cardiovascular DiseasesIndian Journal of Forensic Medicine & Toxicology20210 иқтибос

    ABIABI:AkademIndex/openalex/2021.article.002392

13. Modern Approach to Non-Drug Treatment of Dyslipidemia

    M N Badridinnova, D E Tursunova

    МақолаLipoproteins and Cardiovascular Health20210 иқтибос

    ABIABI:AkademIndex/openalex/2021.article.008514

14. EFFECTIVENESS OF ANTIHYPERTENSIVE DRUG THERAPY IN OUTPATIENT PATIENTS WITH CARDIOVASCULAR DISEASES AND SEVERE LIPID METABOLISM DISORDERS

    M N Badridinnova, Tursunova D. E

    МақолаLipoproteins and Cardiovascular Health20210 иқтибос

    ABIABI:AkademIndex/openalex/2021.article.010301

15. Statins and dementia: effect of statins beyond the treatment of dyslipidaemia

    Jamol Uzokov

    БошқаLipoproteins and Cardiovascular HealthEuropean Journal of Preventive Cardiology20210 иқтибос

    ABIABI:AkademIndex/openalex/2021.other.000002

16. TIMES TO ACT. Italian-Spanish-Polish-Uzbek Expert Forum Position Paper 2022. Dyslipidemia and arterial hypertension: The two most important and modifiable risk factors in clinical practice

    Krzysztof J. Filipiak‬, Miguel Camafort, Matteo Cameli +9

    МақолаLipoproteins and Cardiovascular HealthCardiology Journal20220 иқтибос

    ABIABI:AkademIndex/openalex/2022.article.001294

17. PREVENTION OF CORONARY HEART DISEASE

    Iskandarova Shakhnoza, Amilova Asalya

    МақолаDiabetes, Cardiovascular Risks, and LipoproteinsThe American Journal of Medical Sciences and Pharmaceutical Research20220 иқтибос

    ABIABI:AkademIndex/openalex/2022.article.005361

18. Advantages of aspirin in the prevention of cardiovascular disease

    M Niladri, Gayatri Devi, Prateek Porwal +4

    МақолаInflammatory mediators and NSAID effectsInternational Journal of Health Sciences20220 иқтибос

    ABIABI:AkademIndex/openalex/2022.article.005434

19. Gender Differences in 10-Year Mortality in Patients with Coronary Artery Disease with Elevated Lipoprotein(a): In Search of Invisible Guardian Angel

    Aleksandr B. Shek, Rano B. Alieva, А. А. Абдуллаев +5

    МақолаLipoproteins and Cardiovascular HealthInternational Journal of Biomedicine20220 иқтибос

    ABIABI:AkademIndex/openalex/2022.article.005469

20. Polymorphism in the apolipoprotein C3 gene and coronary lesions in patients with CHD

    Р Алиева, A. Eshpulatov, Aleksandr B. Shek

    МақолаLipoproteins and Cardiovascular HealthAtherosclerosis20220 иқтибос

    ABIABI:AkademIndex/openalex/2022.article.007489

21. Clopidogrel efficacy after percutaneous coronary interventions considering with CYP2C19 genetic polymorphisms in patients with coronary heart disease

    Jamol Uzokov, B. Alyavi, A. Kh. Abdullaev +2

    МақолаAntiplatelet Therapy and Cardiovascular DiseasesAtherosclerosis20220 иқтибос

    ABIABI:AkademIndex/openalex/2022.article.007497

22. PCSK9 pathway-noncoding RNAs crosstalk: Emerging opportunities for novel therapeutic approaches in inflammatory atherosclerosis

    Ghaidaa Raheem Lateef Al‐Awsi, Methaq Hadi Lafta, Hamzah H. Kzar +9

    Шарҳ мақолаLipoproteins and Cardiovascular HealthInternational Immunopharmacology20220 иқтибос

    ABIABI:AkademIndex/openalex/2022.review-article.000029

23. Cardiovascular risk prediction: from classical statistical methods to machine learning approaches

    Michela Sperti, Marta Malavolta, Federica Staunovo Polacco +6

    Шарҳ мақолаCardiovascular Function and Risk FactorsMinerva Cardiology and Angiology20220 иқтибос

    ABIABI:AkademIndex/openalex/2022.review-article.000061

24. Coronary heart disease in patients with human immunodeficiency virus infection

    Amina M. Alieva, M. A. Batov, E. A. Skripnichenko +7

    МақолаHIV-related health complications and treatmentsRussian Medicine20230 иқтибос

    ABIABI:AkademIndex/openalex/2023.article.001853

25. Two approaches to modeling the risk of progressive atherosclerosis

    Н. Г. Ложкина, Yu. E. Voskoboynikov, V. N. Kopylov +2

    МақолаHealthcare Systems and Public HealthSiberian Journal of Clinical and Experimental Medicine20230 иқтибос

    ABIABI:AkademIndex/openalex/2023.article.002869